DPP4/CD26, a potential cofactor for SARS-CoV-2 infection [27,28], is also downregulated by apabetalone, with potential synergistic effects with ACE2 reductions that block cellular SARS-CoV-2 uptake and infection. The gene discussed is DPP4; the disease is infection.